AstraZeneca
AZN
$68.22
Share price
-1.04%
Change (1 day)
4.44%
Change (1 year)
Categories
Earnings for AstraZeneca (AZN)
Earnings in 2023 (TTM): $7.54 B
According to AstraZeneca's latest financial reports the company's current earnings (TTM) are $7.54 B. In 2022 the company made an earning of $3.84 B an increase over its 2021 earnings that were of $1.03 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for AstraZeneca from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $7.54 B | 96.18% |
| 2022 | $3.84 B | 271.59% |
| 2021 | $1.03 B | -80.18% |
| 2020 | $5.22 B | 75.23% |
| 2019 | $2.98 B | -12.66% |
| 2018 | $3.41 B | -8.99% |
| 2017 | $3.74 B | -24.05% |
| 2016 | $4.93 B | 19.11% |
| 2015 | $4.14 B | 87.68% |
| 2014 | $2.20 B | -41.4% |
| 2013 | $3.76 B | -56.57% |
| 2012 | $8.67 B | -35% |
| 2011 | $13.34 B | 11.18% |
| 2010 | $12.00 B | 0% |
| 2009 | $12.00 B | 31.29% |
| 2008 | $9.14 B | 12.97% |
| 2007 | $8.09 B | -1.48% |
| 2006 | $8.21 B | 26.36% |
| 2005 | $6.50 B | -2526.12% |
| 2004 | -$0.27 B | -106.52% |
| 2003 | $4.11 B | 2.94% |
| 2002 | $3.99 B | -32.95% |
| 2001 | $5.95 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.83 B | 229.18% | 🇺🇸 USA |
 Novartis NVS | $9.16 B | 21.52% | 🇨🇭 Switzerland |
 Pfizer PFE | $24.22 B | 221.02% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.27 B | -16.82% | 🇺🇸 USA |
 Eli Lilly LLY | $7.28 B | -3.51% | 🇺🇸 USA |
 Sanofi SNY | $9.96 B | 32.04% | 🇫🇷 France |
 Biogen BIIB | $3.12 B | -58.63% | 🇺🇸 USA |
 Merck MRK | $6.38 B | -15.35% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.69 B | 15.27% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.96 B | 5.63% | 🇬🇧 UK |